A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

被引：2

作者：

Dang, Anhthu ^{[1
]}

Knee, Deborah ^{[2
]}

Wang, Cui Ying ^{[2
]}

Gao, Feng ^{[2
]}

Liu, Guoxun ^{[2
]}

Briones, Sergio ^{[2
]}

Coulson, Michelle ^{[3
]}

Makofske, Jessica ^{[1
]}

Mansfield, Keith ^{[1
]}

Liu, May ^{[1
]}

Mulvey, Tanya ^{[1
]}

Meseck, Emily K. ^{[4
]}

Woolfenden, Steve ^{[1
]}

Buchanan, Sean G. ^{[2
]}

Steensma, David ^{[1
]}

Askoxylakis, Vasileios ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Cambridge, MA USA

[2] Novartis Inst BioMed Res, San Diego, CA USA

[3] Novartis Pharmaceut, Preclin Safety, Cambridge, MA USA

[4] Novartis Pharmaceut, Preclin Safety, E Hanover, NJ USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159910

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：11564 / 11565

页数：2

共 50 条

[21] Antibody-Drug Conjugate Targets
Teicher, B. A.
CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 982 - 1004
[22] An Immunosuppressive Antibody-Drug Conjugate
Wang, Rongsheng E.
Liu, Tao
Wang, Ying
Cao, Yu
Du, Jintang
Luo, Xiaozhou
Deshmukh, Vishal
Kim, Chan Hyuk
Lawson, Brian R.
Tremblay, Matthew S.
Young, Travis S.
Kazane, Stephanie A.
Wang, Feng
Schultz, Peter G.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3229 - 3232
[23] The antibody-drug conjugate landscape
Flynn, Patrick
Suryaprakash, Smruthi
Grossman, Dan
Panier, Val
Wu, John
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 577 - 578
[24] In vitro and in vivo targeting and therapy of an antibody-drug conjugate (IMMU-110) in B-cell malignancies
Sapra, P
Stein, R
Pickett, J
Govindan, SV
Cardillo, TM
Damoci, C
Sheerin, A
Hansen, HJ
Horak, ID
Griffiths, GL
Goldenberg, DM
BLOOD, 2004, 104 (11) : 898A - 898A
[25] Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
Sedlik, Christine
Heitzmann, Adele
Viel, Sophie
Sarkouh, Rafik Ait
Batisse, Cornelie
Schmidt, Frederic
De la Rochere, Philippe
Amzallag, Nathalie
Osinaga, Eduardo
Oppezzo, Pablo
Pritsch, Otto
Sastre-Garau, Xavier
Hubert, Pascale
Amigorena, Sebastian
Piaggio, Eliane
ONCOIMMUNOLOGY, 2016, 5 (07):
[26] Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy
Hau, Andrew
Zhu, Tong
Wang, Rengang
Lau, Megan
Li, Lingna
Li, Xiaoqing
Sun, Yingqing
Kovacs, Ernest
Khasanov, Alisher
Deng, Dalun
Yan, Zheng
Knight, Robert D.
Kaufmann, Gunnar F.
Ji, Henry
Li, Hui
Zhang, Hong
BLOOD, 2019, 134
[27] Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
Capone, Emily
Piccolo, Enza
Fichera, Imma
Ciufici, Paolo
Barcaroli, Daniela
Sala, Arturo
De laurenzi, Vincenzo
Iacobelli, Valentina
Iacobelli, Stefano
Sala, Gianluca
ONCOTARGET, 2017, 8 (36) : 60368 - 60377
[28] POPULATION PHARMACOKINETICS OF BRENTUXIMAB VEDOTIN, AN ANTIBODY-DRUG CONJUGATE (ADC), IN PATIENTS WITH CD30-POSITIVE HEMATOLOGIC MALIGNANCIES.
Li, H.
Han, T. H.
Hunder, N.
Jang, G.
Zhao, B.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S41 - S42
[29] EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF BRENTUXIMAB VEDOTIN, AN ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH CD30-POSITIVE HEMATOLOGIC MALIGNANCIES
Han, T. H.
Grove, L. E.
Lynch, C. M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S17 - S18
[30] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
Tsumura, Ryo
Anzai, Takahiro
Manabe, Shino
Takashima, Hiroki
Koga, Yoshikatsu
Yasunaga, Masahiro
Matsumura, Yasuhiro
CANCER SCIENCE, 2021, 112 : 725 - 725

← 1 2 3 4 5 →